⌘K
Loading ticker…
Black Diamond Therapeutics, Inc. Common Stock · Healthcare · Pharmaceutical Products
As of 2026-06-26, Black Diamond Therapeutics, Inc. Common Stock (BDTX) has a 3-month relative strength percentile of 17 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 38. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 7.6%, relative volume 5.27×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
17 is not yet a leadership-grade RS read, Market Stance is 47
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
BDTX is in a stage 4 downtrend, week 4. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -30.2% / -40.0%.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | BDTX Jan avg: 32.05% median: 29.54% win: 100% σ: 27.00% n: 4 2022-04-12 → 2026-05-29 | BDTX Feb avg: -7.78% median: -12.04% win: 25% σ: 32.34% n: 4 2022-04-12 → 2026-05-29 | BDTX Mar avg: -7.83% median: -7.61% win: 25% σ: 13.11% n: 4 2022-04-12 → 2026-05-29 | BDTX Apr avg: -1.57% median: 9.68% win: 60% σ: 23.03% n: 5 2022-04-12 → 2026-05-29 | BDTX May avg: -0.28% median: -14.18% win: 40% σ: 28.11% n: 5 2022-04-12 → 2026-05-29 | BDTX Jun avg: 56.82% median: 29.14% win: 75% σ: 79.04% n: 4 2022-04-12 → 2026-05-29 (current) | BDTX Jul avg: 13.52% median: 18.97% win: 75% σ: 30.19% n: 4 2022-04-12 → 2026-05-29 | BDTX Aug avg: -3.74% median: -4.35% win: 50% σ: 6.51% n: 4 2022-04-12 → 2026-05-29 | BDTX Sep avg: -13.18% median: -21.76% win: 25% σ: 36.47% n: 4 2022-04-12 → 2026-05-29 | BDTX Oct avg: -8.18% median: -16.19% win: 50% σ: 34.84% n: 4 2022-04-12 → 2026-05-29 | BDTX Nov avg: 2.81% median: -2.29% win: 25% σ: 14.77% n: 4 2022-04-12 → 2026-05-29 | BDTX Dec avg: -12.56% median: -16.97% win: 25% σ: 23.68% n: 4 2022-04-12 → 2026-05-29 |